Login/Sign Up
Bongriv-35 Tablet 1's
₹65*
₹55*
MRP ₹65
15% CB
₹10 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
About Bongriv-35 Tablet 1's
Bongriv-35 Tablet 1's belongs to the class of medicines called bisphosphonates used to treat or prevent osteoporosis (weak and brittle bones) caused by menopause or taking steroids for a long time. Also, Bongriv-35 Tablet 1's is used to treat Paget’s disease of bone. Osteoporosis is a bone disease that weakens and thins bones by decreasing bone density, common in post-menopausal women. As the density of bones decreases, they weaken and are more likely to break.
Bongriv-35 Tablet 1's contains Risedronic acid that works by binding to the bone tightly and preventing the removal of calcium by osteoclasts (a type of bone cell that destroys bone tissue). This prevents osteoclasts from breaking down the bone and keeps the bones strong and minimizes the risk of bones breaking.
Take Bongriv-35 Tablet 1's as prescribed by your doctor. You are advised to take Bongriv-35 Tablet 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience headache, nausea, indigestion, stomach pain, cramps or discomfort, constipation, diarrhea, pain in the muscles, joints, or bones, feeling of fullness or bloating. Most of these side effects of Bongriv-35 Tablet 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Bongriv-35 Tablet 1's, any sugars, or any other medicines, please tell your doctor. Avoid taking Bongriv-35 Tablet 1's if you are pregnant or breastfeeding and consult a doctor. Bongriv-35 Tablet 1's is not recommended for children below 18 years as the safety and effectiveness were not established. Avoid taking Bongriv-35 Tablet 1's if you have hypocalcemia (low calcium levels in the blood) and severe kidney problems. Avoid drinking alcohol as heavy drinking may also cause bone loss. Avoid smoking as it may decrease bone mineral density and increase the risk of fractures. Bongriv-35 Tablet 1's may cause osteonecrosis of the jaw (ONJ) in some patients. Therefore, if you experience any problems with teeth or mouth such as loose teeth, swelling or pain, non-healing of sores, or discharge, consult your doctor and dentist as these might be signs of osteonecrosis of the jaw.
Uses of Bongriv-35 Tablet 1's
Medicinal Benefits
Risedronate (risedronate sodium) helps your bones stay as strong as possible. Bongriv-35 Tablet 1's is used to treat osteoporosis and Paget’s disease. In osteoporosis, risedronate slows down the cells that break down bone. This maintains bone density and makes your bones stronger and less likely to break. In Paget's disease of bone, risedronate reduces the abnormal bone turnover that this condition causes. This helps to reduce deformity and pain and makes your bones stronger and less likely to break.
Side Effects of Bongriv-35 Tablet 1's
Directions for Use
Storage
Drug Warnings
If you are allergic to Bongriv-35 Tablet 1's, or any other medicines, please tell your doctor. Avoid taking Bongriv-35 Tablet 1's if you are pregnant or breastfeeding and consult a doctor. Bongriv-35 Tablet 1's is not recommended for children below 18 years as the safety and effectiveness were not established. Avoid taking Bongriv-35 Tablet 1's if you have hypocalcaemia (low calcium levels in the blood) and severe kidney problems. Avoid drinking alcohol as heavy drinking may also cause bone loss. If you have parathyroid hormone abnormalities, lack of vitamin D, swelling, numbness or pain in the jaw, loose tooth, heavy jaw feeling or had Barrett’s oesophagus (abnormal change in the cells lining the lower oesophagus), inform your doctor before taking Bongriv-35 Tablet 1's. Avoid smoking as it may decrease bone mineral density and increase the risk of fractures. Bongriv-35 Tablet 1's may cause osteonecrosis of the jaw (ONJ) in some patients. Therefore, if you experience any problems with teeth or mouth such as loose teeth, swelling or pain, non-healing of sores or discharge, consult your doctor and dentist as these might be signs of osteonecrosis of the jaw. Your doctor may prescribe calcium and vitamin D supplements if you do not take sufficient from your diet.
Therapeutic Class
Drug Interactions
Drug-Drug Interaction: Bongriv-35 Tablet 1's may interact with antacids (magnesium hydroxide, aluminium hydroxide), iron and calcium supplements.
Drug-Food Interaction: Avoid taking Bongriv-35 Tablet 1's with milk as it contains calcium and may reduce the effectiveness of Bongriv-35 Tablet 1's.
Drug-Disease Interaction: Avoid taking Bongriv-35 Tablet 1's if you have hypocalcaemia (low calcium levels in the blood) and severe kidney problems. If you have parathyroid hormone abnormalities, lack of vitamin D, swelling, numbness or pain in the jaw, loose tooth, heavy jaw feeling or had Barrett’s oesophagus (abnormal change in the cells lining the lower oesophagus), inform your doctor before taking Bongriv-35 Tablet 1's.
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
What if I have taken an overdose of Bongriv-35 Tablet 1's
Special Advise
You are advised to inform your dentist that you are taking Bongriv-35 Tablet 1's before undergoing any dental surgery.
Disease/Condition Glossary
Osteoporosis: It is a bone disease that weakens and thins bones by decreasing bone density. As the density of bones decreases, they weaken and are more likely to break. Post-menopausal women are more likely to develop osteoporosis than men because, at menopause, women’s ovaries stop producing oestrogen (a female hormone) that is essential to keep bones healthy. Following menopause, bone loss occurs, making bones weak and more likely to break. Also, long term use of steroids may affect bone strength and cause osteoporosis in both men and women. Signs and symptoms include back pain caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone that breaks much more easily than expected.
Paget’s bone disease: In Paget’s disease, bone remodelling (removal of old bone and replacement with new bone material) is too quick, and new bone is formed in a disordered manner making it weaker than normal. If left untreated, the bone may become deformed, painful and break.
Alcohol
Caution
The interaction of alcohol with Bongriv-35 Tablet 1's is unknown. Please consult a doctor before consuming alcohol with Bongriv-35 Tablet 1's.
Pregnancy
Caution
Bongriv-35 Tablet 1's is a category C pregnancy drug and is given to pregnant women only if the doctor thinks benefits outweigh risks. Please consult a doctor if you are pregnant.
Breast Feeding
Caution
Bongriv-35 Tablet 1's is given to breastfeeding women only if the doctor thinks benefits are greater than risks. Please consult a doctor if you are breastfeeding.
Driving
Caution
Bongriv-35 Tablet 1's usually does not affect your ability to drive or operate machinery.
Liver
Caution
Take Bongriv-35 Tablet 1's with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.
Kidney
Caution
Take Bongriv-35 Tablet 1's with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required. Avoid taking Bongriv-35 Tablet 1's if you have severe kidney problems.
Children
Unsafe
Bongriv-35 Tablet 1's is not recommended for children below 18 years as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes